RETN and cancer: Recent studies have demonstrated that circulating resistin levels are significantly elevated in patients with breast, gastric, colorectal, lung and endometrial cancers [20,21,22,23,24], suggesting that serum resistin can be a potential diagnostic biomarker for cancers.